VASH2 and breast carcinoma: Several studies have shown that VASH2 is highly expressed in HCC, breast cancer, and ovarian cancer, and that there is a close association between VASH2 expression and EMT in these malignancies.13, 14, 18 However, the role of VASH2 in the EMT process of PC cells remains unclear.